1. Zhao, Shuhua, Cheng, Lu, Shi, Yuan, Yun, Qinghui, Yang, Hong. 2021. MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway. In Cell death & disease, 12, 18. doi:10.1038/s41419-020-03336-6. https://pubmed.ncbi.nlm.nih.gov/33414447/
2. Xie, Chaozheng, Li, Kang, Li, Ya, Wang, Wang, Wei, Zhengqiang. 2022. CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathway. In Frontiers in oncology, 12, 881487. doi:10.3389/fonc.2022.881487. https://pubmed.ncbi.nlm.nih.gov/36106106/
3. Bartsakoulia, Marina, Pyle, Angela, Troncoso-Chandía, Diego, Eisner, Verónica, Horvath, Rita. . A novel mechanism causing imbalance of mitochondrial fusion and fission in human myopathies. In Human molecular genetics, 27, 1186-1195. doi:10.1093/hmg/ddy033. https://pubmed.ncbi.nlm.nih.gov/29361167/
4. Doğanlar, Zeynep Banu, Doğanlar, Oğuzhan, Kurtdere, Kardelen, Chasan, Tourkian, Turgut, Esra. 2021. Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model. In Toxicology in vitro : an international journal published in association with BIBRA, 75, 105191. doi:10.1016/j.tiv.2021.105191. https://pubmed.ncbi.nlm.nih.gov/33962019/
智鼠故事 
